Hearing Genomics

Overview

About this study

Aims, purpose, or objectives:

1) Develop hypotheses related to how the human genome and genetic variants affect hearing loss in children and adults.

2) Understand phenotypes of hearing loss on a deeper level by combining and analyzing information from audiometric, genetic, and radiologic data.

3) Explore genetic variants with an unknown significance to develop an understanding of their potential significance and explore other genes may influence an individual's hearing ability.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

 

Subject population (children, adults, groups):  All children and adults seen at the Mayo Clinic for hearing loss or deafness

 

Inclusion Criteria: Permanent hearing loss.

 

Exclusion Criteria:  Foster children, prisoners

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lisa Schimmenti, M.D.

Open for enrollment

Contact information:

Lisa Schimmenti M.D.

(507)538-1392

Schimmenti.Lisa@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available